DelveInsight, a prominent player in healthcare analysis, presents a detailed exploration of Parkinson's Disease through its Market Insights report. This comprehensive analysis spans current treatment methodologies, emerging drugs, market share of individual therapies, and the projected market size from 2019 to 2032. The report's segmentation covers 7 Major Markets (7MM), including the United States, EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan.

Click here to know Parkinson’s Disease Market

Key Takeaways from the Parkinson's Disease Market Report:

  1. Parkinson's Disease Market Size and Prevalence:
  • The Parkinson's disease market in the 7MM reached an approximate value of USD 3.2 billion in 2022.
  • DelveInsight estimates that around 2.5 million cases of diagnosed prevalent Parkinson's disease existed in the 7MM in 2022.
Leading Parkinson's Disease Companies and Drug Development:
  • Industry leaders like Cerevel Therapeutics, Pfizer, Pharma Two B, AbbVie, Biogen, Denali Therapeutics, among others, are actively engaged in the development of innovative Parkinson's disease drugs.
  • The pipeline includes promising therapies like Tavapadon, P2B001, ABBV-951 (foscarbidopa/foslevodopa), BIIB122/DNL151, demonstrating the ongoing commitment to advancing Parkinson's disease treatment.
Parkinson's Disease Epidemiological Segmentation:
  • DelveInsight's analysis points to an estimated 2.5 million diagnosed prevalent cases of Parkinson's disease in the 7MM for the year 2022.
  • Parkinson's disease exhibits a male-dominant pattern, with 54% of cases in males and 46% in females within the 7MM.

Click here to know Parkinson’s Disease Market

Parkinson's Disease Overview:

Parkinson's disease stands as a degenerative disorder marked by the loss of nerve cells in the substantia nigra, a critical brain region controlling movement. While the exact cause remains elusive, a blend of genetic and environmental factors is suspected. The disease manifests primarily with motor symptoms such as bradykinesia, stiffness, rest tremor, and postural instability. Non-motor symptoms, including cognitive impairment, depression, pain, and autonomic disturbances, significantly impact patients' quality of life.

Parkinson's Disease Epidemiological Segmentation:

DelveInsight's Parkinson's disease market report provides a nuanced epidemiological analysis for the study period spanning 2019–2032. This includes segmentation into diagnosed prevalent population, gender-specific diagnosed prevalent population, age-specific diagnosed prevalent population, and stage-specific diagnosed prevalent population.

Parkinson's Disease Treatment Landscape:

The treatment landscape for Parkinson's disease involves a range of drugs, with Levodopa serving as the gold standard for managing motor problems. Medications such as dopamine agonists, MAO B inhibitors, catechol o-methyltransferase inhibitors, and others aim to alleviate motor symptoms. INBRIJA (levodopa), an inhalation therapy, supplements daily carbidopa-levodopa medications, providing relief from "off-episodes" and motor symptoms.

Pipeline Parkinson's Disease Therapies and Key Companies:

The pipeline of Parkinson's disease therapies includes potential breakthroughs like Tavapadon, P2B001, ABBV-951, BIIB122/DNL151, spearheaded by major players like Cerevel Therapeutics, Pfizer, AbbVie, Biogen, showcasing a commitment to advancing Parkinson's disease management.

Parkinson's Disease Market Dynamics:

While the Parkinson's disease market is poised for evolution, driven by research, emerging therapies, and enhanced diagnosis rates, challenges such as the absence of a cure, reliance on symptomatic treatments, side effects, and undetected cases pose potential impediments. Nevertheless, a robust pipeline and progress in disease-modifying treatments instill optimism for the future.

In conclusion, DelveInsight's Parkinson's Disease Market Insights report delivers a comprehensive understanding of the current landscape, potential breakthroughs, and existing challenges. This valuable resource empowers stakeholders to make informed decisions in the dynamic realm of Parkinson's disease research and treatment.

Click here to know Parkinson’s Disease Market

Trending Reports:

Healthcare Consulting Service

DelveInsights multidimensional, purposeful, and credible pharma and medtech consulting services will aid in the acceleration of product services, including aspects such as congress intelligence, conference coverage, CI asset/indication tracking, brand presence and penetration assessment, drug therapy uptake, and diagnostic landscape assessment to overcome several market challenges.

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us:

Ankit Nigam

Assistant Manager Marketing

[email protected]